drugset / Trial / NCT01441206
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
Phase 1
Terminated
2 enrolled
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to learn more about the safety and dosing of rifampin in infants.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-04
- Completion
- 2012-04
Outcome
Outcome not reported
Stopped: “Study to be redesigned.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifampicin | Small molecule | 10 mg/kg | — |
| Subject | Rifampicin | Small molecule | 15 mg/kg | — |
| Subject | Rifampicin | Small molecule | 20 mg/kg | — |